CINC Corp. (4378) AI Stock Analysis

• Market Cap: ¥1.41B
• Dividend Yield: N/A
• Average Volume (3M): 3.24K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.09
• Revenue Growth: -8.08%
• EPS Growth: -428.39%
• Country: JP
• Employees: 118
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Infrastructure
• EPS (TTM): -12.22
• Shares Outstanding: 3,523,075
• 10 Day Avg. Volume: 4,280
• 30 Day Avg. Volume: 3,236
• PEG Ratio: 0.02
• Price to Book (P/B): 1.49
• Price to Sales (P/S): 0.86
• P/FCF Ratio: -11.03
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 48 Neutral
• Price Target: ¥497.00 ▲(0.00% Upside)
• Action: Reiterated Date: 01/14/26
• Date: Action: Reiterated 01/14/26

The score is held back primarily by the 2025 shift to operating/net losses and negative operating/free cash flow despite strong revenue growth and healthy gross margin. Technicals are neutral-to-soft (below key longer-term moving averages with negative MACD), and valuation is constrained by a negative P/E and lack of dividend support.

Positive Factors

Recurring revenue / subscription model

A subscription and licensing model for EHR and patient-engagement software creates durable, predictable revenue streams and higher customer switching costs. Over months this supports margin scalability, smoother renewals-driven cash flow, and opportunities to upsell analytics and services to existing clients.

Strong top-line growth

Re-accelerating revenue indicates product-market fit and growing adoption of CINC’s health-tech offerings. Sustained mid-to-high revenue growth over several quarters supports investment in R&D and platform expansion, improving unit economics and competitive positioning if driven by repeatable sales execution.

High gross margins

A ~63% gross margin reflects the inherent scalability and low incremental cost of software/analytics delivery. This structural margin advantage provides room to absorb fixed operating investments and, if revenue growth persists, to drive operating leverage and margin expansion over the medium term.

Negative Factors

Negative operating and free cash flow

Material negative operating and free cash flow reverses prior positive cash generation and reduces financial flexibility. If cash consumption persists, the company may need external financing or to cut strategic investments, raising execution risk and constraining sustainable product rollouts over the next several quarters.

Profitability swung to losses

The sharp reset from modest profitability to negative margins signals cost or pricing pressure that erodes return on incremental revenue. Persistent negative operating profitability undermines the business’s ability to self-fund growth and risks long-term margin dilution absent clear, sustainable cost control or pricing recovery.

Negative returns on equity

A negative ROE indicates shareholder capital is not generating returns and reflects poor capital efficiency. Even with zero debt and a sizable equity base, persistent negative ROE reduces reinvestment effectiveness and investor optionality, pressuring long-term capacity to fund growth without dilutive financing.

CINC Corp. Business Overview & Revenue Model

Company Description

Cinc Corp., a data solution company that researches and develops machine learning and artificial intelligence technologies. The company provides a SaaS tool that provides accurate data analysis solutions using natural language processing technology. It also offers consulting services based on big data. The company was founded in 2014 and is based in Tokyo, Japan.

How the Company Makes Money

CINC Corp. generates revenue primarily through the sale of its software solutions and subscription-based services. The key revenue streams include licensing fees from its EHR systems, subscription fees from its patient engagement platforms, and consulting services related to the implementation and optimization of its software. Additionally, CINC Corp. may engage in partnerships with healthcare providers and institutions to offer customized solutions, which can further enhance its earnings. The company's focus on data analytics also opens avenues for monetizing insights derived from healthcare data, creating additional revenue opportunities.

CINC Corp. Financial Statement Overview

Summary

Strong 2025 revenue growth (+32.1%) and healthy gross margin (63.5%) are outweighed by a sharp profitability reset (net margin fell to -8.4% with EBIT/EBITDA negative) and materially weaker cash generation (operating and free cash flow both around -¥142M). The balance sheet is low risk with zero debt, but returns deteriorated (ROE -14.5%).

Income Statement

Revenue growth re-accelerated in 2025 (annual revenue up 32.1%), but profitability deteriorated sharply: net margin moved from a positive 2.6% in 2024 to -8.4% in 2025, with EBIT and EBITDA also turning negative. Gross margin remains healthy (63.5% in 2025), yet the swing from profits in 202FY2024 to losses in 2025 points to meaningful cost pressure and weaker earnings quality despite solid top-line momentum.

Balance Sheet

The balance sheet is conservatively positioned with zero debt in 2025 (down from modest leverage in prior years) and a sizable equity base (equity of ~¥1.06B vs. assets of ~¥1.38B). The key weakness is returns: return on equity fell to -14.5% in 2025 after being modestly positive in 2024, indicating that while leverage risk is low, shareholder capital is currently not generating profits.

Cash Flow

Cash generation weakened materially in 2025: operating cash flow was -¥141.2M and free cash flow was -¥142.4M, reversing the positive cash profile seen in 2024. The company also showed volatility across years (negative free cash flow in 2023, positive in 2024, negative again in 2025), which raises execution risk and reduces financial flexibility if the loss-making period extends.

Breakdown	Oct 2025	Oct 2024	Oct 2023	Oct 2022	Oct 2021
Income Statement
Total Revenue	1.82B	1.99B	1.95B	1.81B	1.31B
Gross Profit	1.16B	1.32B	1.37B	1.31B	920.11M
EBITDA	-55.04M	119.01M	69.19M	337.87M	222.15M
Net Income	-152.59M	51.92M	5.26M	201.39M	129.54M
Balance Sheet
Total Assets	1.38B	1.91B	1.84B	2.03B	1.89B
Cash, Cash Equivalents and Short-Term Investments	847.80M	1.35B	1.28B	1.52B	1.60B
Total Debt	0.00	16.68M	71.61M	151.62M	244.44M
Total Liabilities	324.35M	395.63M	358.62M	527.64M	594.58M
Stockholders Equity	1.06B	1.51B	1.48B	1.50B	1.29B
Cash Flow
Free Cash Flow	-142.42M	161.72M	-168.10M	113.05M	245.04M
Operating Cash Flow	-141.19M	205.42M	-17.02M	185.50M	289.83M
Investing Cash Flow	-40.18M	-56.42M	-127.91M	-174.81M	-26.13M
Financing Cash Flow	-323.28M	-74.26M	-100.87M	-91.06M	811.06M

CINC Corp. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 497.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4378, the sentiment is Negative. The current price of 497 is above the 20-day moving average (MA) of 489.05, above the 50-day MA of 493.02, and below the 200-day MA of 546.45, indicating a bearish trend. The MACD of -4.46 indicates Positive momentum. The RSI at 33.73 is Neutral, neither overbought nor oversold. The STOCH value of <0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4378.

CINC Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3993	68 Neutral	¥107.39B	47.69	8.26%	―	28.88%	27.51%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
9417	58 Neutral	¥3.76B	8.01	―	2.04%	14.34%	―
3914	57 Neutral	¥16.47B	39.45	―	―	3.17%	-16.66%
4180	56 Neutral	¥84.95B	32.94	―	0.18%	25.88%	80.30%
4378	48 Neutral	¥1.41B	-9.41	―	―	-8.08%	-428.39%
3680	44 Neutral	¥3.53B	-1.97	―	1.17%	-21.76%	-5832.28%